Company file · ALAB
Astera Labs
Singapore was Astera Labs' fastest-growing region in FY2025, up 853.3%
Revenue rose 115.1% to $853M in FY2025, from $396M in FY2024. Net income was $219M, against a net loss of $83M a year earlier. Singapore was the largest region, at 32% of revenue.
Key facts
Astera Labs (Nasdaq: ALAB) closed fiscal 2025 on Dec 31, 2025 with revenue of $853M, up 115.1% from a year before; net income came to $219M, compared with −$83M. Its newest quarterly report covers the three months to Sep 30, 2026: revenue of $585M, up 153.7% on the same stretch of the prior year, and net income of $183M. Broken down by region, Singapore led with 32% of fiscal 2025 revenue. Sources: 10-K for fiscal 2025 (filed Feb 20, 2026) and 10-Q for the quarter ended Sep 30, 2026 (filed Nov 4, 2026).
Source: 10-K FY2025, filed Feb 20, 2026
Source: 10-Q filed May 6, 2026 · 10-Q filed Aug 5, 2026 · 10-Q filed Nov 4, 2026
How it makes money
By region in FY2025: Singapore (32%), China (30%), Taiwan (29%) and Non-US (5%), as shares of total revenue. Total revenue was $853M.
Source: 10-K FY2025
Learn more: Revenue vs. net income · Gross, operating and net margin
What changed last quarter
Comparing Q3 2026 (Jul to Sep 2026) compared with Q3 2025 (Jul to Sep 2025)
Each pair of bars shows the dollar amount for both quarters. Longer bar, more money. Bars in a group share one scale.
Q3 2026Q3 2025
Company
Source: Astera Labs 10-Q for the quarter ended Sep 30, 2026, filed Nov 4, 2026
By region
Source: Astera Labs 10-Q for the quarter ended Sep 30, 2026, filed Nov 4, 2026
The bull case and the bear case
The bull case
- Revenue rose 115.1% in FY2025 to $853M, from $396M a year earlier. 10-K, FY2025
- Net income was $219M in FY2025, against a net loss of $83M in FY2024. 10-K, FY2025
- Operating cash flow rose 133.6% in FY2025 to $319M. 10-K, FY2025
- Revenue in the quarter ended Sep 30, 2026 was $585M, up 153.7% on a year earlier. 10-Q, quarter ended Sep 30, 2026
The bear case
- Diluted shares rose 36.8% in FY2025, which spreads profit across more shares. 10-K, FY2025
- Taiwan revenue fell 8.3% in FY2025 to $247M. 10-K, FY2025
- The company's own risk factors are in Item 1A of its 10-K. Risks common in this industry include chip cycles; customer concentration; export rules and trade. 10-K, Item 1A
What optimists and skeptics tend to point to, each tied to a filing. Ticker Sage doesn't pick a side, and neither list is a reason to buy or sell.
What the company does
Astera Labs is in the semiconductors industry, part of the information technology sector. The SEC files it under Semiconductors & Related Devices.
The full description of Astera Labs' business is in Item 1 of its 10-K, linked below. This page shows its revenue by region.
Its fiscal year ends in December; the latest, FY2025, ended Dec 31, 2025.
Source: 10-K, Item 1 Business
Risks common in this industry
These are general risks for companies in the semiconductors industry. They are not a summary of Astera Labs’s own risk factors; for those, read Item 1A of its latest 10-K, linked below.
- Chip cyclesDemand for chips swings between shortages and gluts, and orders can be cut quickly.
- Customer concentrationA few large customers can account for much of sales.
- Export rules and tradeExport controls and tariffs can limit sales to some customers or countries.
- Manufacturing supplyIt depends on outside factories and suppliers, and disruptions can delay products.
- Competition and design winsCustomers pick suppliers product by product, so losing a design can cost years of sales.
Source: 10-K, Item 1A Risk Factors (the company's own list, in the company's words)
Three years of key numbers
Every number links to its filing; hover for the XBRL tag. A dash means the number isn't cleanly available, and we don't estimate it.
| US$ | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $116M | $396M | $853M |
| Net income | −$26M | −$83M | $219M |
| Operating cash flow | −$13M | $137M | $319M |
| Cash & equivalents (year end) | $45M | $80M | $168M |
| Diluted shares | 37M | 131M | 180M |
- Revenue: Total revenue for the fiscal year, as the company reports it on its income statement.
- Net income: Net income attributable to the company's shareholders, after all costs, interest and taxes.
- Operating cash flow: Cash the business brought in from its day-to-day operations during the year (cash flow statement).
- Cash & equivalents: Cash and short-term investments that count as cash equivalents on the balance sheet. Excludes longer-dated marketable securities.
- Diluted shares: Weighted average shares outstanding for the year, including the effect of options and stock awards.
Learn more: How to read an income statement · Earnings per share, basic and diluted · Free cash flow · How to read a balance sheet · Growth rate calculator · P/E calculator · Market cap calculator · Free cash flow calculator · Return on equity and assets calculator
Explainers for this page
- The cash flow statement
- Risk factors (Item 1A)
- Debt-to-equity ratio
- Market cap and enterprise value
- Return on equity (ROE)
- The proxy statement (DEF 14A)
- Schedule 13D vs. 13G
Guides to terms this file uses, with real numbers from filings.
About these numbers
What we left out
- Total debt: the company's filing data doesn't carry a consistent debt total for the years shown, so it isn't shown.
Recent filings
| Form | Filed | Period |
|---|---|---|
| 10-Q | Nov 4, 2026 | Sep 30, 2026 |
| 10-Q | Aug 5, 2026 | Jun 30, 2026 |
| 10-Q | May 6, 2026 | Mar 31, 2026 |
| DEF 14A | Apr 23, 2026 | Jun 4, 2026 |
| 10-K | Feb 20, 2026 | Dec 31, 2025 |
What's in this filing
The quotes below come from Item 1 (Business) of the Form 10-K Astera Labs filed on Feb 20, 2026, its annual report for the fiscal year ended Dec 31, 2025.
The latest quarterly report in the table above is the Form 10-Q filed Nov 4, 2026 for the quarter ended Sep 30, 2026.
A 10-K has audited annual financial statements and the company's own description of its business and risks; a 10-Q has unaudited quarterly statements.
Building on years of experience with a singular focus on addressing connectivity challenges in data-centric systems, we have developed and deployed our leading Intelligent Connectivity Platform built from the ground up for cloud and AI infrastructure.
Our Intelligent Connectivity Platform comprises of semiconductor-based, high-speed, mixed-signal connectivity products that integrate a matrix of microcontrollers and sensors, and COSMOS, our software suite, which is embedded in our connectivity products and integrated into our customers’ systems.
Short excerpts quoted from the filing. The full document is on SEC.gov.
Learn more: 10-K vs. 10-Q vs. 8-K · Form 4 insider filings · Fiscal years and quarters
Common questions about Astera Labs
How does Astera Labs make money?
Fiscal 2025 revenue: $853M. By region in FY2025: Singapore (32%), China (30%), Taiwan (29%) and Non-US (5%), as shares of total revenue. Total revenue was $853M. Source: 10-K for fiscal 2025, filed Feb 20, 2026.
What was Astera Labs's revenue in fiscal 2025?
$853M, up 115.1% from fiscal 2024 ($396M). The year ended Dec 31, 2025; for fiscal 2023 the figure was $116M. Source: 10-K for fiscal 2025, filed Feb 20, 2026.
Is Astera Labs profitable?
Net income was $219M in fiscal 2025 (compared with −$83M; fiscal 2024 was −$83M). That counts as a GAAP profit. The latest quarter, ended Sep 30, 2026: net income was $183M. The page's About these numbers section explains what is included. Source: 10-K for fiscal 2025, filed Feb 20, 2026.
What did Astera Labs report in its latest quarterly filing?
For the three months to Sep 30, 2026: revenue $585M (up 153.7% from $231M) and net income $183M (up 100.8% from $91M). Source: 10-Q for the quarter ended Sep 30, 2026, filed Nov 4, 2026.
What are the main risks Astera Labs faces?
Astera Labs's own risk factors are in Item 1A of its 10-K for fiscal 2025, filed Feb 20, 2026. Risks that are common among companies in the semiconductors industry include Chip cycles; customer concentration; export rules and trade; manufacturing supply; competition and design wins. The first: Demand for chips swings between shortages and gluts, and orders can be cut quickly. Source: 10-K, Item 1A Risk Factors.
Where do these Astera Labs numbers come from?
The 10-K filed Feb 20, 2026 (fiscal 2025) and the 10-Q filed Nov 4, 2026 (quarter ended Sep 30, 2026), as published in the SEC's XBRL data. Click any number to open the filing it came from. Methodology explains how fiscal years and missing numbers are handled.
Tracked funds that report owning Astera Labs
- Millennium Management: 1,562,022 shares, reported value $556.0M at Sep 30, 2026 (+158.4% in shares since the filing for Jun 30, 2026). Form 13F filed Nov 16, 2026.
- Baillie Gifford: 786,876 shares, reported value $280.1M at Sep 30, 2026 (+260.2% in shares since the filing for Jun 30, 2026). Form 13F filed Nov 9, 2026.
- Two Sigma Investments: 640,725 shares, reported value $228.1M at Sep 30, 2026 (+1,232.5% in shares since the filing for Jun 30, 2026). Form 13F filed Nov 16, 2026.
- Renaissance Technologies: 570,800 shares, reported value $203.2M at Sep 30, 2026 (+272.1% in shares since the filing for Jun 30, 2026). Form 13F filed Nov 12, 2026.
- Bridgewater Associates: 10,805 shares, reported value $3.8M at Sep 30, 2026 (+989.2% in shares since the filing for Jun 30, 2026). Form 13F filed Nov 16, 2026.
- Maverick Capital: 3,029 shares, reported value $1.1M at Sep 30, 2026 (−99.7% in shares since the filing for Jun 30, 2026). Form 13F filed Nov 16, 2026.
From each fund’s latest Form 13F, which is filed up to 45 days after quarter end and lists long positions in US-listed stocks only. A listing here is a fact about a filing, not a view on the stock. What a 13F does and doesn’t show.
Disclosures
- Editor holdings in ALAB
- The editor holds no position in Astera Labs (ALAB). As of Nov 11, 2026.
- Trading rule
- The editor does not buy or sell ALAB from 3 days before to 3 days after this page is published or substantively updated.
- Compensation
- Nobody paid for this page. No affiliate links on this page.
- Sources
- The company's SEC filings, linked next to each number or, for charts, in the source line under them.
- Last updated
- Nov 20, 2026
General education, the same for every reader. Not a recommendation to buy, sell or hold ALAB, and it doesn't consider your situation.
Compare with peers
| Company | Fiscal year | Revenue | Revenue growth | Net income |
|---|---|---|---|---|
| Astera LabsALAB | FY2025 | $853M | +115.1% | $219M |
| NvidiaNVDA | FY2026 | $215.9B | +65.5% | $120.1B |
| BroadcomAVGO | FY2025 | $63.9B | +23.9% | $23.1B |
| MicronMU | FY2026 | $133.2B | +256.3% | $85.0B |
| AMD | FY2025 | $34.6B | +34.3% | $4.3B |
Each row is that company’s latest fiscal year from its own 10-K, using its own revenue and net income lines. Fiscal years end in different months, and line definitions differ (banks, insurers and oil companies count revenue differently), so this is a rough side-by-side, not a like-for-like comparison.
More company files
- INTC Intel
- AMAT Applied Materials
- LRCX Lam Research
- TXN Texas Instruments
- QCOM Qualcomm
- SNDK Sandisk
- MRVL Marvell Technology
- ADI Analog Devices
- KLAC KLA
- NXPI NXP Semiconductors
- MPWR Monolithic Power Systems
- TER Teradyne
- MCHP Microchip Technology
- ON ON Semiconductor
- Q Qnity Electronics
- SWKS Skyworks Solutions
- FSLR First Solar
- ENTG Entegris
- MTSI MACOM Technology Solutions
- AAPL Apple
- MSFT Microsoft
- AMZN Amazon
- GOOGL Alphabet
- META
- BRK.B Berkshire Hathaway
- JPM JPMorgan Chase
- LLY Eli Lilly
- WMT Walmart
- V Visa
- XOM ExxonMobil
New to filings? Learn has explainers built on real filings and Tools has calculators. Methodology & Disclosures covers where every number comes from.